公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2022 | Malignant granular cell tumour at the interventricular septum | Lou, Weng-Kin; HENG-WEN CHOU ; WEI-WU CHEN ; CHE-YU HSU ; JENG-WEI CHEN | Interactive cardiovascular and thoracic surgery | 0 | 0 | |
2018 | Managing the adverse effects related to immune checkpoint inhibitors | Kuo H.-H.; WEI-WU CHEN | Journal of Nursing | 3 | 0 | |
2016 | New hope for HER2-positive metastatic breast cancer treatment: Trastuzumab emtansine (T-DM1) from the perspective of nursing care | Kuo H.-H.; WEI-WU CHEN | Journal of Nursing | 2 | 0 | |
2023 | New targeted treatments for advanced sarcomas | CHIA-CHEN LI ; WEI-WU CHEN | Current opinion in oncology | 1 | 0 | |
2018 | Next frontiers in systemic therapy for soft tissue sarcoma | Yen C.-C.; WEI-WU CHEN | Chinese Clinical Oncology | 12 | 0 | |
2014 | No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen | WEI-WU CHEN ; Chen H.-M.; CHING-HUNG LIN ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; Lai M.-S.; YEN-SHEN LU | Breast Cancer Research and Treatment | 10 | 8 | |
2020 | Optimal clinical management and the molecular biology of angiosarcomas | WEI-WU CHEN ; Burns J.; Jones R.L.; Huang P.H. | Cancers | 15 | 16 | |
2013 | Personalized medicine for metastatic breast cancer | WEI-WU CHEN ; Bedard P.L. | Current Opinion in Oncology | 7 | 6 | |
2020 | A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors | JIH-HSIANG LEE ; WEI-WU CHEN ; CHIH-HUNG HSU ; Yen Y.-H.; CHIH-HSIN YANG ; ANN-LII CHENG ; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; CHIA-CHI LIN | Investigational New Drugs | 39 | 36 | |
2018 | A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer | WEI-WU CHEN ; Yeh D.-C.; Chao T.-Y.; CHING-HUNG LIN ; Chow L.W.-C.; DWANG-YING CHANG ; Hsieh Y.-Y.; Huang S.-M.; ANN-LII CHENG ; YEN-SHEN LU ; Taiwan Breast Cancer Consortium | Japanese Journal of Clinical Oncology | 4 | 3 | |
2015 | A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis | Wu P.-F.; CHING-HUNG LIN ; CHING-HUA KUO ; WEI-WU CHEN ; Yeh D.-C.; Liao H.-W.; Huang S.-M.; ANN-LII CHENG ; YEN-SHEN LU | BMC Cancer | 48 | 36 | |
2016 | A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer | BANG-BIN CHEN ; YEN-SHEN LU ; CHING-HUNG LIN ; WEI-WU CHEN ; Wu P.-F.; CHAO-YU HSU ; CHIH-WEI YU ; Wei S.-Y.; ANN-LII CHENG ; TIFFANY TING-FANG SHIH | BMC Cancer | 20 | 17 | |
2023 | Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer | WEI-WU CHEN ; Hsiao, Wen; Dai, Ming-Shen; CHING-HUNG LIN ; DWANG-YING CHANG ; I-CHUN CHEN ; MING-YANG WANG ; Chang, Shu-Han; Huang, Shu-Min; ANN-LII CHENG ; Wu, Ko-Wen; Tan, Kien Thiam; YEN-SHEN LU | Breast cancer research and treatment | 0 | 0 | |
2019 | Primary cardiac sarcomas: A multi-national retrospective review | WEI-WU CHEN ; Loong H.H.; Srikanthan A.; Zer A.; Barua R.; Butany J.; Cusimano R.J.; Liang Y.-C.; Chang C.-H.; Iakobishvili Z.; Razak A.R.A.; Lewin J. | Cancer Medicine | 32 | 25 | |
2019 | Primary Ewing Family of Tumor Arising in the Ovary: A Case Report | Li, Yi-Ping; Chang, Koping; WEI-WU CHEN ; Lee, Shu-Ping; CHI-AN CHEN ; WEN-FANG CHENG | International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists | 4 | 2 | |
2019 | Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients – A Taiwanese study | Wu T.-H.; Lee L.J.-H.; CHANG-TSU YUAN ; WEI-WU CHEN ; CHIH-HSIN YANG | Journal of the Formosan Medical Association | 7 | 6 | |
2013 | Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy | WEI-WU CHEN ; CHIA-CHI LIN ; TA-CHEN HUANG ; ANN-LII CHENG ; KUN-HUEI YEH ; CHIH-HUNG HSU | Anticancer Research | 11 | 11 | |
2023 | The proteomic landscape of soft tissue sarcomas | Burns, Jessica; Wilding, Christopher P; Krasny, Lukas; Zhu, Xixuan; Chadha, Madhumeeta; Tam, Yuen Bun; Ps, Hari; Mahalingam, Aswanth H; Lee, Alexander T J; Arthur, Amani; Guljar, Nafia; Perkins, Emma; Pankova, Valeriya; Jenks, Andrew; Djabatey, Vanessa; Szecsei, Cornelia; McCarthy, Frank; Ragulan, Chanthirika; Milighetti, Martina; Roumeliotis, Theodoros I; Crosier, Stephen; Finetti, Martina; Choudhary, Jyoti S; Judson, Ian; Fisher, Cyril; Schuster, Eugene F; Sadanandam, Anguraj; WEI-WU CHEN ; Williamson, Daniel; Thway, Khin; Jones, Robin L; Cheang, Maggie C U; Huang, Paul H | Nature communications | 5 | 1 | |
2022 | Revisiting Adjuvant Hormone Therapy in Premenopausal Women With Breast Cancer: Escalation and De-Escalation | Chen, Hsing-Wu; WEI-WU CHEN | JCO oncology practice | 0 | 0 | |
2020 | The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma | Heng M.; Gupta A.; Chung P.W.; Healey J.H.; Vaynrub M.; Rose P.S.; Houdek M.T.; Lin P.P.; Bishop A.J.; Hornicek F.J.; Chen Y.-L.; Lozano-Calderon S.; Holt G.E.; Han I.; Biau D.; Niu X.; Bernthal N.M.; Ferguson P.C.; Wunder J.S.; Ueda T.; Kakunaga S.; Kawai A.; Sugiura H.; Kidani T.; Kunisasa T.; Ozaki T.; Ae K.; Nagano A.; Ohno T.; Hiraoka K.; Yamamoto N.; Tsuchiya H.; Matsumoto Y.; Yanagawa T.; Nakayama R.; Morioka H.; Kubo T.; Simose S.; Yamagami Y.; Yamamoto T.; Kawasaki M.; Torigoe T.; Yazawa Y.; Akiyama T.; Gokita T.; Manabe J.; Kaya M.; Emori M.; Nakamura T.; Matsumine A.; Sugihara S.; Yokouchi M.; Komiya S.; Suehara Y.; Takagi T.; Kawamoto T.; Wasa J.; Yonemoto T.; Ishii T.; Baba I.; Hoshi M.; Hamada K.; Naka N.; Sotobori T.; Araki N.; Okuma T.; Goto T.; Kobayashi H.; Kawano H.; Hosaka M.; Futani H.; Hiraga H.; Nishida Y.; Griffin A.; Razak A.R.A.; Shultz D.B.; Catton C.; Robinson S.; Patel S.R.; Lewis V.O.; Guadagnolo B.A.; DeLaney T.; Wang H.; Raskin K.; Callan A.K.; Henshaw R.; Isler M.; Mottard S.; Chen W.-M.; Traub F.; WEI-WU CHEN ; Turcotte R.E.; Davidson D.; Tunn P.-U.; Loong H.; Ghert M.; Werier J.; Clarkson P.; Abraham J.A.; Japanese Musculoskeletal Oncology Group (JMOG), Soft Tissue Osteosarcoma International Collaborative (STOIC) | European Journal of Cancer | 49 | 42 | |